U.S. flag

An official website of the United States government

NM_000465.4(BARD1):c.2324_2325del (p.Leu775fs) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Oct 12, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000780945.2

Allele description [Variation Report for NM_000465.4(BARD1):c.2324_2325del (p.Leu775fs)]

NM_000465.4(BARD1):c.2324_2325del (p.Leu775fs)

Gene:
BARD1:BRCA1 associated RING domain 1 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
2q35
Genomic location:
Preferred name:
NM_000465.4(BARD1):c.2324_2325del (p.Leu775fs)
HGVS:
  • NC_000002.12:g.214728685_214728686del
  • NG_012047.3:g.86026_86027del
  • NM_000465.4:c.2324_2325delMANE SELECT
  • NM_001282543.2:c.2267_2268del
  • NM_001282545.2:c.971_972del
  • NM_001282548.2:c.914_915del
  • NM_001282549.2:c.785_786del
  • NP_000456.2:p.Leu775fs
  • NP_001269472.1:p.Leu756fs
  • NP_001269474.1:p.Leu324fs
  • NP_001269477.1:p.Leu305fs
  • NP_001269478.1:p.Leu262fs
  • LRG_297t1:c.2324_2325del
  • LRG_297:g.86026_86027del
  • LRG_297p1:p.Leu775fs
  • NC_000002.11:g.215593409_215593410del
  • NG_012047.2:g.86019_86020del
  • NM_000465.2:c.2324_2325del
  • NM_000465.2:c.2324_2325delTT
  • NM_000465.3:c.2324_2325del
  • NM_000465.3:c.2324_2325delTT
  • NR_104212.2:n.2289_2290del
  • NR_104215.2:n.2232_2233del
  • NR_104216.2:n.1488_1489del
  • p.L775Rfs*19
Protein change:
L262fs
Links:
dbSNP: rs587782046
NCBI 1000 Genomes Browser:
rs587782046
Molecular consequence:
  • NM_000465.4:c.2324_2325del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001282543.2:c.2267_2268del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001282545.2:c.971_972del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001282548.2:c.914_915del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001282549.2:c.785_786del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NR_104212.2:n.2289_2290del - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_104215.2:n.2232_2233del - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_104216.2:n.1488_1489del - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000918618Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Oct 12, 2017)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000918618.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: The BARD1 c.2324_2325delTT (p.Leu775ArgfsX3+) variant results in a frameshift and a 15 amino acid extension of the protein. One in silico tool predicts a benign outcome for this variant. This variant is absent in 245804 control chromosomes in gnomAD. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as uncertain significance. The variant of interest has not, to our knowledge, been reported in affected individuals via publications nor evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as a VUS until additional evidence becomes available.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024